News | March 31, 2026
Granules Life Sciences receives VAI Classification for Shamirpet facility
The inspection is now closed, and no regulatory action has been recommended
The inspection is now closed, and no regulatory action has been recommended
The hospitals house over 25 super-speciality centres and Centres of Excellence in Cardiology, Neurology, Oncology, Paediatrics, Orthopaedics, ENT, Obstetrics and Gynaecology, General Surgery, Internal Medicine, Critical Care, and Chronic Disease Management
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
The initiative, funded entirely under the company’s CSR programme, is expected to reach over a million lives
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
On a proforma basis in Q3 FY26, revenues grew by 15% YoY to Rs. 2,366 Cr and operating EBITDA increased by 22% YoY to Rs. 503 Cr
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
The company will respond to the US FDA within the stipulated timelines
Subscribe To Our Newsletter & Stay Updated
